CW and RW

Comment

A third of all schizophrenia cases go undiagnosed

Only around two in three individuals with schizophrenia are diagnosed by a physician, likely due to misdiagnosis of the condition.

GlobalData Healthcare
Comment

DLBCL: a rapidly evolving treatment landscape with a crowded pipeline

Comment

Arcutis boasts positive data for topical Phase III candidate Roflumilast

Comment

Roche therapeutic gantenerumab fails trial expectations for Alzheimer’s Disease

Comment

Florida suffers Vibrio vulnificus outbreak in wake of Hurricane Ian

Comment

Roche’s gantenerumab failure boosts prospects for Eisai and Biogen’s lecanemab